Who Are the Core Customers of Novozymes Company?

Novozymes core customers are Fortune 500 CPG and industrial manufacturers that buy enzymes at scale to cut costs or improve yields; examples include household-care giants where a 1 percent yield lift equals millions in incremental profit, and grain processors such as Archer-Daniels-Midland.

Secondary customer groups are food and beverage manufacturers, large animal feed producers, and agricultural enterprises buying enzymes and microbial products for processing efficiency, shelf-life, and crop input performance across global supply chains.

Novozymes customers are primarily institutional businesses (B2B) in industrial biotechnology and manufacturing; recent moves also target mixed institutional buyers in human health and nutrition after combining with Chr. Hansen, serving pharmaceutical and functional-food clients using microbial strains for probiotics.

In 2025/2026 the most commercially important segment shifted toward human health and nutrition (pharma and functional foods) while traditional industrial enzyme buyers-CPG, food processors, biofuels, and agriculture-remain critical; Novozymes reported combined portfolio synergies and target cross-sales to Chr. Hansen customers, supporting revenue growth in these segments.

Novozymes core customers concentrate in North America and Europe where the EU Green Deal and U.S. biofuel mandates push adoption of industrial biotechnology customers and sustainable enzymes; these regions still account for the largest share of sales and R&D collaboration.

Latin America, led by Brazil, shows the most aggressive growth in Novozymes customers in bioenergy and biofuels as second – generation ethanol ramps; emerging markets in Asia, Africa, and parts of Latin America drive uptake in Agriculture & Animal Health for microbial bio – stimulants.

Household Care remains the largest revenue contributor, representing approximately 25 to 30 percent of total sales, with detergent manufacturers and surfactant formulators among top Novozymes customers; the firm is also strong in industrial enzyme supply and partnerships with biotech companies using Novozymes solutions.

In 2025-2026 the Bioenergy vertical in Brazil grew fastest among Novozymes customer segments as second – generation ethanol capacity scaled; in the U.S., Food, Beverage & Human Health customers-driven by personalized nutrition and gut – health products-show rising enzyme and probiotic demand.

Novozymes moves beyond traditional enzyme buyers by selling to food and beverage manufacturers Novozymes, bioenergy producers, and biotech companies using Novozymes, leveraging the same microbial fermentation infrastructure to serve baking, bio-ethanol, detergents, and new human health applications.

Specialized technical sales teams and vertical-focused reps keep Novozymes core customers engaged by delivering domain-specific formulations and onsite process support to industrial biotechnology customers and food processing clients, preserving trust with legacy detergent, animal feed, and brewery partners.

Repeat demand and renewals are strong where enzyme integration is sticky-bakeries and bioenergy plants show high switching costs; Novozymes customers in agriculture and crop protection and wastewater partners often move to multi-year contracts and wider product adoption across production lines.

The key growth lever is platform scalability: post-2024 merger integration allowed Novozymes to add health and pharma enzyme lines without large new CAPEX. By 2026 the company maintains a best-in-class EBITDA margin in the 26 to 29 percent range while expanding into higher-margin health segments, showing complementary growth to its industrial core. Read more on Leadership and Ownership of Novozymes Company Leadership and Ownership of Novozymes Company